News All the latest news and information about the care, research, teaching and management we do at Vall d’Hebron Barcelona Hospital Campus. Don't miss any details! Year202520242023 MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Fulltext search Search Combination of antitumor drugs improves survival in patients with pediatric cancer 09/01/2024 Clinical trial to test a new gene therapy in patients with immunodeficiency 13/12/2023 Positive preliminary results of the study of HIPRA's vaccine against COVID-19 05/12/2023 Vall d'Hebron organizes the meeting of the European research group on pediatric sarcomas 01/12/2023 Vall d'Hebron promotes ReALLNet to promote research in acute lymphoblastic leukaemia 18/10/2023 RBDCOV members meet at Vall d'Hebron to advance the development of BIMERVAX vaccine 11/10/2023 Projects in pediatric hematology and oncology at the Iberian congress of the specialty 26/06/2023 A genetic study indicates that ADHD is associated with lower life expectancy 09/05/2023 Vall d'Hebron participates in a guide for clinical trials with drug combinations 04/05/2023 62% of children with a ventricular assist device receive a new heart 03/05/2023 Largest genetic study in ADHD identifies new genome regions associated with the disorder 24/02/2023 Vall d'Hebron will develop medicines for children with a 3D printer 31/01/2023 Four Vall d’Hebron mental health projects awarded in the 2021 TV3 La Marató charity event 03/11/2022 Dr Amanda Rodríguez presents her book 'Siente lo que comes' 05/04/2022 New study shows the relationship between insomnia and ADHD improvement 03/03/2022 New report with the collaboration of Vall d’Hebron calls for clearer definition of treatment-resistant depression 15/12/2021 Vall d'Hebron studies the effectiveness of online interventions for cannabis addiction in young people 07/12/2021 Families with transplanted children feel more understood due to the widespread use of prevention measures, such as masks 15/09/2021 Vall d'Hebron participates in a study that identifies 33 new genetic variants associated with bipolar disorder 16/05/2021 Vall d’Hebron enrolls the first patient in a Phase IIb clinical trial by Oryzon for Borderline Personality Disorder 28/03/2021 Pagination « First First page ‹ Previous Previous page 1 2 3 Next › Next page Last » Last page